Advertisement

European Journal of Clinical Pharmacology

, Volume 74, Issue 6, pp 679–700 | Cite as

Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria

  • Fabiane Raquel MotterEmail author
  • Janaína Soder Fritzen
  • Sarah Nicole Hilmer
  • Érika Vieira Paniz
  • Vera Maria Vieira Paniz
Review

Abstract

Purpose

Potentially inappropriate medication (PIM) use causes preventable adverse drug reactions in older patients. Several assessment tools have been published to identify and avoid PIM use. In this systematic literature review, we aim to provide summaries and comparisons of validated PIMs lists published between 1991 and 2017 internationally.

Methods

In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA), we performed a systematic review of articles describing the development and validation of criteria for identification of PIMs among older people published between January 1991 and April 2017. The searches were conducted on PUBMED, AgeLine, Academic Search, Academic Search Premier, and CINAHL. We identified the most common medications/classes described as PIM. We also identified the drug–disease interactions and drug–drug interactions reported among criteria.

Results

From 2933 articles screened, 36 met our inclusion criteria. The majority used the Delphi method to validate their criteria. We identified 907 different medications/classes, 536 different drug disease interactions involving 84 diseases/conditions, and 159 drug–drug interactions. Benzodiazepines and nonsteroidal anti-inflammatory drugs were the medications most commonly reported as potentially inappropriate for older people.

Conclusion

Although approaches aimed at detecting inappropriate prescribing have intensified in recent years, we observed limited overlap between different PIM lists. Additionally, some PIM lists did not provide special considerations of use and alternative therapies to avoid PIMs. These facts may compromise the use of PIM lists in clinical practice. Future PIM lists should integrate information about alternative therapies and special considerations of use in order to help clinicians in the drug prescription.

Keywords

Inappropriate prescribing Potentially inappropriate medication list Drug-related side effects and adverse reactions Aged 

Notes

Acknowledgements

We thank to the Coordination for the Improvement of Higher Education Personnel, National Council for Scientific and Technological Development for the support that they are providing for development of this study.

Author contributions

FRM and VPM participated in all stages of this project, from the design and interpretation of data to its final writing. FRM and JSF conducted the development of search strategies, selection procedure, data extraction, data synthesis, and analysis. EVP contributed to the database organization and data extraction. SNH contributed to the critical review and writing of this manuscript. All authors participated in the discussions, result interpretation, and approved the final version of manuscript for submission.

Funding

FRM was supported by the Coordination for the Improvement of Higher Education Personnel—CAPES through a doctorate at University of Vale do Rio dos Sinos, Brazil. FRM was also supported by CAPES through a sandwich doctorate fellowship at University of Sydney, Australia (number grant: 88881.134589/2016-01). This systematic review was funded by the National Council for Scientific and Technological Development-CNPQ (number grant: 426720/2016-4). The funders were not involved in the design or conduct of the study, collection, analysis, or interpretation of the data or preparation or approval of the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

228_2018_2446_MOESM1_ESM.doc (64 kb)
Appendix 1 (DOC 63 kb)
228_2018_2446_MOESM2_ESM.docx (72 kb)
Appendix 2 (DOCX 72 kb)

References

  1. 1.
    Dimitrow MS, Airaksinen MS, Kivela SL, Lyles A, Leikola SN (2011) Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J Am Geriatr Soc 59(8):1521–1530.  https://doi.org/10.1111/j.1532-5415.2011.03497.x CrossRefPubMedGoogle Scholar
  2. 2.
    Renom-Guiteras A, Meyer G, Thurmann PA (2015) The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol 71(7):861–875.  https://doi.org/10.1007/s00228-015-1860-9 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Hedna K, Hakkarainen KM, Gyllensten H, Jonsson AK, Petzold M, Hagg S (2015) Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study. Eur J Clin Pharmacol 71(12):1525–1533.  https://doi.org/10.1007/s00228-015-1950-8 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Morin L, Laroche ML, Texier G, Johnell K (2016) Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc 17(9):862.e861–862.e869.  https://doi.org/10.1016/j.jamda.2016.06.011 CrossRefGoogle Scholar
  5. 5.
    Nyborg G, Straand J, Brekke M (2012) Inappropriate prescribing for the elderly—a modern epidemic? Eur J Clin Pharmacol 68(7):1085–1094.  https://doi.org/10.1007/s00228-012-1223-8 CrossRefPubMedGoogle Scholar
  6. 6.
    Opondo D, Eslami S, Visscher S, de Rooij SE, Verheij R, Korevaar JC, Abu-Hanna A (2012) Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One 7(8):e43617.  https://doi.org/10.1371/journal.pone.0043617 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Corsonello A, Pedone C, Incalzi RA (2010) Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 17(6):571–584.  https://doi.org/10.2174/092986710790416326 CrossRefPubMedGoogle Scholar
  8. 8.
    Mangoni AA, Jackson SH (2004) Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 57(1):6–14.  https://doi.org/10.1046/j.1365-2125.2003.02007.x CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Hanlon JT, Shimp LA, Semla TP (2000) Recent advances in geriatrics: drug-related problems in the elderly. Ann Pharmacother 34(3):360–365.  https://doi.org/10.1345/aph.19140 CrossRefPubMedGoogle Scholar
  10. 10.
    Lund BC, Carnahan RM, Egge JA, Chrischilles EA, Kaboli PJ (2010) Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 44(6):957–963.  https://doi.org/10.1345/aph.1M657A CrossRefPubMedGoogle Scholar
  11. 11.
    Cabre M, Elias L, Garcia M, Palomera E, Serra-Prat M (2017) Avoidable hospitalizations due to adverse drug reactions in an acute geriatric unit. Analysis of 3,292 patients. Med Clin.  https://doi.org/10.1016/j.medcli.2017.06.075
  12. 12.
    Price SD, Holman CD, Sanfilippo FM, Emery JD (2014) Association between potentially inappropriate medications from the Beers criteria and the risk of unplanned hospitalization in elderly patients. Ann Pharmacother 48(1):6–16.  https://doi.org/10.1177/1060028013504904 CrossRefPubMedGoogle Scholar
  13. 13.
    Reich O, Rosemann T, Rapold R, Blozik E, Senn O (2014) Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization. PLoS One 9(8):e105425.  https://doi.org/10.1371/journal.pone.0105425 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Klarin I, Wimo A, Fastbom J (2005) The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 22(1):69–82CrossRefPubMedGoogle Scholar
  15. 15.
    Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG (2005) Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 165(1):68–74.  https://doi.org/10.1001/archinte.165.1.68 CrossRefPubMedGoogle Scholar
  16. 16.
    Muhlack DC, Hoppe LK, Weberpals J, Brenner H, Schottker B (2017) The association of potentially inappropriate medication at older age with cardiovascular events and overall mortality: a systematic review and meta-analysis of cohort studies. J Am Med Dir Assoc 18(3):211–220.  https://doi.org/10.1016/j.jamda.2016.11.025 CrossRefPubMedGoogle Scholar
  17. 17.
    American Geriatrics Society Beers Criteria Update Expert P (2012) American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60(4):616–631.  https://doi.org/10.1111/j.1532-5415.2012.03923.x CrossRefGoogle Scholar
  18. 18.
    American Geriatrics Society Beers Criteria Update Expert P (2015) American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63(11):2227–2246.  https://doi.org/10.1111/jgs.13702 CrossRefGoogle Scholar
  19. 19.
    Bachyrycz A, Dodd MA, Priloutskaya G (2012) Development and dissemination of a statewide system to minimize use of potentially inappropriate medications (PIMs). Med Care 50(11):993–996.  https://doi.org/10.1097/MLR.0b013e31826ecfdc CrossRefPubMedGoogle Scholar
  20. 20.
    Basger BJ, Chen TF, Moles RJ (2012) Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method. BMJ Open 2(5):e001431.  https://doi.org/10.1136/bmjopen-2012-001431 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157(14):1531–1536CrossRefPubMedGoogle Scholar
  22. 22.
    Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151(9):1825–1832CrossRefPubMedGoogle Scholar
  23. 23.
    Castillo-Paramo A, Pardo-Lopo R, Gomez-Serranillos IR, Verdejo A, Figueiras A, Claveria A (2013) Assessment of the appropriateness of STOPP/START criteria in primary health care in Spain by the RAND method. SEMERGEN 39(8):413–420.  https://doi.org/10.1016/j.semerg.2013.01.017 CrossRefPubMedGoogle Scholar
  24. 24.
    Chang CB, Yang SY, Lai HY, Wu RS, Liu HC, Hsu HY, Hwang SJ, Chan DC (2012) Using published criteria to develop a list of potentially inappropriate medications for elderly patients in Taiwan. Pharmacoepidemiol Drug Saf 21(12):1269–1279.  https://doi.org/10.1002/pds.3274 CrossRefPubMedGoogle Scholar
  25. 25.
    Clyne B, Bradley MC, Hughes CM, Clear D, McDonnell R, Williams D, Fahey T, Smith SM, O-Ss t (2013) Addressing potentially inappropriate prescribing in older patients: development and pilot study of an intervention in primary care (the OPTI-SCRIPT study). BMC Health Serv Res 13:307.  https://doi.org/10.1186/1472-6963-13-307 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Fialova DT, Topinkova E, Ballokova A, Matejovska-Kubesova H (2013) 2012 CZ expert consensus for potentially inappropriate medication use in old age: appropriate choice of drugs and drug dosing in geriatric patients (section I), drug-disease interactions in the old age (Section II). Klin Farmakol Farmacie 27(1):18–28Google Scholar
  27. 27.
    Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163(22):2716–2724.  https://doi.org/10.1001/archinte.163.22.2716 CrossRefPubMedGoogle Scholar
  28. 28.
    Galan Retamal C, Garrido Fernandez R, Fernandez Espinola S, Ruiz Serrato A, Garcia Ordonez MA, Padilla Marin V (2014) Prevalence of potentially inappropriate medication in hospitalized elderly patients by using explicit criteria. Farm Hosp 38(4):305–316.  https://doi.org/10.7399/fh.2014.38.4.1148 PubMedGoogle Scholar
  29. 29.
    Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D (2008) STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46(2):72–83CrossRefPubMedGoogle Scholar
  30. 30.
    Holt S, Schmiedl S, Thurmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107(31–32):543–551.  https://doi.org/10.3238/arztebl.2010.0543 PubMedPubMedCentralGoogle Scholar
  31. 31.
    Imai HB, MH FDM (2008) Development of Japanese Beers criteria for inappropriate medication use in elderly patients. Jpn Med Assoc J 137:1348–1358Google Scholar
  32. 32.
    Khodyakov D, Ochoa A, Olivieri-Mui BL, Bouwmeester C, Zarowitz BJ, Patel M, Ching D, Briesacher B (2017) Screening Tool of Older Person's Prescriptions/Screening Tools to Alert Doctors to Right Treatment medication criteria modified for U.S. nursing home setting. J Am Geriatr Soc 65(3):586–591.  https://doi.org/10.1111/jgs.14689 CrossRefPubMedGoogle Scholar
  33. 33.
    Kim DS, Heo SI, Lee SH (2010) Development of a list of potentially inappropriate drugs for the korean elderly using the Delphi method. Healthc Inf Res 16(4):231–252.  https://doi.org/10.4258/hir.2010.16.4.231 CrossRefGoogle Scholar
  34. 34.
    Kim S-O, Jang S, Kim C-M, Kim Y-R, Sohn HS (2015) Consensus validated list of potentially inappropriate medication for the elderly and their prevalence in South Korea. Int J Gerontol 9(3):136–141.  https://doi.org/10.1016/j.ijge.2015.05.013 CrossRefGoogle Scholar
  35. 35.
    Kuhn-Thiel AM, Weiss C, Wehling M, Faep m (2014) Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging 31(2):131–140.  https://doi.org/10.1007/s40266-013-0146-0 CrossRefPubMedGoogle Scholar
  36. 36.
    Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63(8):725–731.  https://doi.org/10.1007/s00228-007-0324-2 CrossRefPubMedGoogle Scholar
  37. 37.
    Lindblad CI, Hanlon JT, Gross CR, Sloane RJ, Pieper CF, Hajjar ER, Ruby CM, Schmader KE (2006) Clinically important drug-disease interactions and their prevalence in older adults. Clin Ther 28(8):1133–1143.  https://doi.org/10.1016/j.clinthera.2006.08.006 CrossRefPubMedGoogle Scholar
  38. 38.
    Maio V, Del Canale S, Abouzaid S, Investigators GAP (2010) Using explicit criteria to evaluate the quality of prescribing in elderly Italian outpatients: a cohort study. J Clin Pharm Ther 35(2):219–229.  https://doi.org/10.1111/j.1365-2710.2009.01094.x CrossRefPubMedGoogle Scholar
  39. 39.
    Mann E, Bohmdorfer B, Fruhwald T, Roller-Wirnsberger RE, Dovjak P, Duckelmann-Hofer C, Fischer P, Rabady S, Iglseder B (2012) Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list. Wien Klin Wochenschr 124(5–6):160–169.  https://doi.org/10.1007/s00508-011-0061-5 CrossRefPubMedGoogle Scholar
  40. 40.
    Mazhar F, Akram S, Malhi SM, Haider N (2017) A prevalence study of potentially inappropriate medications use in hospitalized Pakistani elderly. Aging Clin Exp Res 30:53–60.  https://doi.org/10.1007/s40520-017-0742-7 CrossRefPubMedGoogle Scholar
  41. 41.
    McLeod PJ, Huang AR, Tamblyn RM, Gayton DC (1997) Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 156(3):385–391PubMedPubMedCentralGoogle Scholar
  42. 42.
    Nyborg G, Straand J, Klovning A, Brekke M (2015) The Norwegian general practice—nursing home criteria (NORGEP-NH) for potentially inappropriate medication use: a web-based Delphi study. Scand J Prim Health Care 33(2):134–141.  https://doi.org/10.3109/02813432.2015.1041833 CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213–218.  https://doi.org/10.1093/ageing/afu145 CrossRefPubMedGoogle Scholar
  44. 44.
    Passi A, Margozzini P, Valenzuela E, Hoyl T, Marin PP, Carrasco M, Olea R, Gac H (2016) Inappropriate medication use among Chilean older people. Rev Med Chil 144(4):417–425.  https://doi.org/10.4067/S0034-98872016000400001 CrossRefPubMedGoogle Scholar
  45. 45.
    Pugh MJ, Hanlon JT, Zeber JE, Bierman A, Cornell J, Berlowitz DR (2006) Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure. J Manag Care Pharm 12(7):537–545.  https://doi.org/10.18553/jmcp.2006.12.7.537 PubMedGoogle Scholar
  46. 46.
    Rancourt C, Moisan J, Baillargeon L, Verreault R, Laurin D, Gregoire JP (2004) Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr 4:9.  https://doi.org/10.1186/1471-2318-4-9 CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J (2009) The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 27(3):153–159.  https://doi.org/10.1080/02813430902992215 CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Stuck AE, Beers MH, Steiner A, Aronow HU, Rubenstein LZ, Beck JC (1994) Inappropriate medication use in community-residing older persons. Arch Intern Med 154(19):2195–2200CrossRefPubMedGoogle Scholar
  49. 49.
    Tommelein E, Mehuys E, Petrovic M, Somers A, Van Damme C, Pattyn E, Mattelin K, Boussery K (2016) Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP(3)S-tool. Int J Clin Pharm 38(5):1063–1068.  https://doi.org/10.1007/s11096-016-0366-6 CrossRefPubMedGoogle Scholar
  50. 50.
    Winit-Watjana W, Sakulrat P, Kespichayawattana J (2008) Criteria for high-risk medication use in Thai older patients. Arch Gerontol Geriatr 47(1):35–51.  https://doi.org/10.1016/j.archger.2007.06.006 CrossRefPubMedGoogle Scholar
  51. 51.
    Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, Meyer GS (2001) Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 286(22):2823–2829CrossRefPubMedGoogle Scholar
  52. 52.
    Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G, Clarfield AM, Crome P, Hertogh C, Lesauskaite V, Prada GI, Szczerbinska K, Topinkova E, Sinclair-Cohen J, Edbrooke D, Mills GH (2011) The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med 171(6):550–556.  https://doi.org/10.1001/archinternmed.2011.31 CrossRefPubMedGoogle Scholar
  53. 53.
    Crome P, Lally F, Cherubini A, Oristrell J, Beswick AD, Clarfield AM, Hertogh C, Lesauskaite V, Prada GI, Szczerbinska K, Topinkova E, Sinclair-Cohen J, Edbrooke D, Mills G (2011) Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study. Drugs Aging 28(8):667–677.  https://doi.org/10.2165/11591990-000000000-00000 CrossRefPubMedGoogle Scholar
  54. 54.
    Marriott J, Stehlik P (2012) A critical analysis of the methods used to develop explicit clinical criteria for use in older people. Age Ageing 41(4):441–450.  https://doi.org/10.1093/ageing/afs064 CrossRefPubMedGoogle Scholar
  55. 55.
    Chang CB, Chan DC (2010) Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging 27(12):947–957.  https://doi.org/10.2165/11584850-000000000-00000 CrossRefPubMedGoogle Scholar
  56. 56.
    Kaufmann CP, Tremp R, Hersberger KE, Lampert ML (2014) Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol 70(1):1–11.  https://doi.org/10.1007/s00228-013-1575-8 CrossRefPubMedGoogle Scholar
  57. 57.
    Lucchetti G, Lucchetti AL (2017) Inappropriate prescribing in older persons: a systematic review of medications available in different criteria. Arch Gerontol Geriatr 68:55–61.  https://doi.org/10.1016/j.archger.2016.09.003 CrossRefPubMedGoogle Scholar
  58. 58.
    Duran CE, Azermai M, Vander Stichele RH (2013) Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol 69(7):1485–1496.  https://doi.org/10.1007/s00228-013-1499-3 CrossRefPubMedGoogle Scholar
  59. 59.
    Dalkey NC (1969) The Delphi method: an experimental study of group opinion. Santa Monica, CA: RAND Corporation. Available at: http://www.rand.org/pubs/research_memoranda/RM5888
  60. 60.
    Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C (2011) Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS One 6(6):e20476.  https://doi.org/10.1371/journal.pone.0020476 CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Islam MM, Iqbal U, Walther B, Atique S, Dubey NK, Nguyen PA, Poly TN, Masud JH, Li YJ, Shabbir SA (2016) Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology 47(3–4):181–191.  https://doi.org/10.1159/000454881 CrossRefPubMedGoogle Scholar
  62. 62.
    Zhong G, Wang Y, Zhang Y, Zhao Y (2015) Association between benzodiazepine use and dementia: a meta-analysis. PLoS One 10(5):e0127836.  https://doi.org/10.1371/journal.pone.0127836 CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Clegg A, Young JB (2011) Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing 40(1):23–29.  https://doi.org/10.1093/ageing/afq140 CrossRefPubMedGoogle Scholar
  64. 64.
    Vozoris NT, Fischer HD, Wang X, Anderson GM, Bell CM, Gershon AS, Stephenson AL, Gill SS, Rochon PA (2013) Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Drugs Aging 30(3):183–192.  https://doi.org/10.1007/s40266-013-0056-1 CrossRefPubMedGoogle Scholar
  65. 65.
    Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 47(1):40–50CrossRefPubMedGoogle Scholar
  66. 66.
    Finkle WD, Der JS, Greenland S, Adams JL, Ridgeway G, Blaschke T, Wang Z, Dell RM, VanRiper KB (2011) Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc 59(10):1883–1890.  https://doi.org/10.1111/j.1532-5415.2011.03591.x CrossRefPubMedGoogle Scholar
  67. 67.
    Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S (2014) Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med 174(6):890–898.  https://doi.org/10.1001/jamainternmed.2014.949 CrossRefPubMedGoogle Scholar
  68. 68.
    Cheng JS, Huang WF, Lin KM, Shih YT (2008) Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan. Int J Geriatr Psychiatry 23(6):618–624.  https://doi.org/10.1002/gps.1950 CrossRefPubMedGoogle Scholar
  69. 69.
    Johnson CF, Frei C, Downes N, McTaggart SA, Akram G (2016) Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study. Br J Gen Pract 66(647):e410–e415.  https://doi.org/10.3399/bjgp16X685213 CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Ray WA, Stein CM, Byrd V, Shorr R, Pichert JW, Gideon P, Arnold K, Brandt KD, Pincus T, Griffin MR (2001) Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial. Med Care 39(5):425–435CrossRefPubMedGoogle Scholar
  71. 71.
    Marcum ZA, Hanlon JT (2010) Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults. Ann Longterm Care 18(9):24–27PubMedPubMedCentralGoogle Scholar
  72. 72.
    Hines LE, Murphy JE (2011) Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother 9(6):364–377.  https://doi.org/10.1016/j.amjopharm.2011.10.004 CrossRefPubMedGoogle Scholar
  73. 73.
    Marengoni A, Pasina L, Concoreggi C, Martini G, Brognoli F, Nobili A, Onder G, Bettoni D (2014) Understanding adverse drug reactions in older adults through drug-drug interactions. Eur J Intern Med 25(9):843–846.  https://doi.org/10.1016/j.ejim.2014.10.001 CrossRefPubMedGoogle Scholar
  74. 74.
    Budnitz DS, Lovegrove MC, Shehab N, Richards CL (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365(21):2002–2012.  https://doi.org/10.1056/NEJMsa1103053 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Fabiane Raquel Motter
    • 1
    • 2
    Email author
  • Janaína Soder Fritzen
    • 1
  • Sarah Nicole Hilmer
    • 2
  • Érika Vieira Paniz
    • 3
  • Vera Maria Vieira Paniz
    • 1
  1. 1.Postgraduate Program in Collective HealthUniversity of Vale do Rio dos Sinos (UNISINOS)Sao LeopoldoBrazil
  2. 2.Department of Clinical Pharmacology and Aged Care, Kolling InstituteRoyal North Shore Hospital and University of SydneySt LeonardsAustralia
  3. 3.Faculty of Medical SciencesFederal University of Rio Grande do Sul (UFRGS)Porto AlegreBrazil

Personalised recommendations